Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Baricitinib is a promising treatment for alopecia areata.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Baricitinib successfully treated severe hair loss.